<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ETHNOPHARMACOLOGICAL RELEVANCE: Mercurialis annua L., Bongardia chrysogonum L., and Viscum cruciatum Sieb have been traditionally used by local herbalists in Jordan for the treatment of hematopoietic <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>AIM OF THE STUDY: To determine the anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, anti-inflammatory and anti-microbial potentials of the three extracts against two of the most common <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> in the Jordanian populations; Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0006775'>Multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: The anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> activity was tested against the two cell lines (BJAB Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and U266 <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>) using the <z:chebi fb="0" ids="53233">MTT</z:chebi> and trypan blue assays </plain></SENT>
<SENT sid="3" pm="."><plain>The agar dilution assay was used to study the anti-microbial activity against <z:mp ids='MP_0001796'>Gram-positive</z:mp> bacteria, <z:mp ids='MP_0001795'>Gram-negative</z:mp> bacteria, anaerobic bacteria and yeast </plain></SENT>
<SENT sid="4" pm="."><plain>The pro-inflammatory cytokines interleukin (IL) -1β, IL-8 and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α (TNF-α) were measured in the pretreated cell lines using ELISA assay to determine the anti-inflammatory activity of Viscum cruciatum Sieb against the two cell lines </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The results show no evidence of stimulation of <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> by any of the three extracts comprising cell lines from <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e>, but Viscum cruciatum Sieb showed a selective anticancer activity against BJAB cells, with IC(50) value of 14.21μg/ml </plain></SENT>
<SENT sid="6" pm="."><plain>The antimicrobial effect was only noticed with Viscum cruciatum extract by inhibiting Staphylococcus aureus, Candida albicans and Propionibacterium <z:hpo ids='HP_0001061'>acne</z:hpo>, but not Pseudomonas aeruginosa at MIC of 1.25, 1.25, 0.625 and &lt;5mg/ml, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>The highest activity was against the anaerobic bacteria Propionibacterium <z:hpo ids='HP_0001061'>acne</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Viscum cruciatum Sieb extract showed an inhibitory effect on the pro-inflammatory cytokine IL-8, but it increased TNF-α and IL-1β secretions in BJAB cells </plain></SENT>
<SENT sid="9" pm="."><plain>Whereas, it had an inhibitory effect on TNF-α and IL-1β cytokines while it enhanced IL-8 secretions in U266 cells </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Among the three tested herbal extracts used in the traditional medicine in Jordan, only Viscum cruciatum Sieb showed high anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and anti-microbial potentials </plain></SENT>
<SENT sid="11" pm="."><plain>They also had an anti-inflammatory effect </plain></SENT>
<SENT sid="12" pm="."><plain>These observations raise the prospects of using Viscum cruciatum Sieb for treatment of diseases associated with some <z:mp ids='MP_0001794'>bacterial</z:mp> and <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infections</z:e>, for imbalanced cytokine production and for enhancing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and other immunotherapies </plain></SENT>
</text></document>